VIDEO: RPE detachments respond to ranibizumab in HARBOR trial

LAS VEGAS — At the American Academy of Ophthalmology annual meeting, David A. Eichenbaum, MD, discusses the relationship between macular atrophy, retinal pigment epithelial detachment and response to treatment with ranibizumab in the HARBOR trial.

Full Story →